Dermatology Patient Pathways


exp date isn't null, but text field is

For Dermatology Patient Pathways click here
The National Dermatology Patient Pathways should be used in association with drug recommendations and guidance in this section to inform the management of acne, alopecia, atopic eczema, benign skin lesions, generalised and local pruritus, hand and foot eczema, molluscum contagiosum, nail dystrophy, non-melanoma skin cancers, psoriasis, rosacea, scabies, solar (actinic) keratoses and Bowen’s Disease, suspicious pigmented lesions, urticaria, and viral warts.

Last reviewed: 26 October 2021

Next review: 31 October 2024

Version: 1

Reviewer Name(s): Patricia Hannam

Document Id: TAM480